Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496

(2013) Andrew M. Evens et al.   BRITISH JOURNAL OF HAEMATOLOGY

ABVD in Older Patients With Early-Stage Hodgkin Lymphoma Treated Within the German Hodgkin Study Group HD10 and HD11 Trials

(2013) Boris Böll et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study

(2012) S. J. Proctor et al.   BLOOD

Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia

(2012) Prahlad Ho et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009

(2011) J. Sjoberg et al.   BLOOD

Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma

(2011) B. Boll et al.   BLOOD

A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era

(2011) A. M. Evens et al.   BLOOD

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

(2011) Simonetta Viviani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

(2010) T. V. Halbsguth et al.   BLOOD

Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas

(2010) Anas Younes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hodgkin lymphoma in the elderly: A clinical review of treatment and outcome, past, present and future

(2009) S.J. Proctor et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY